Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/48163
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMansfield, P.-
dc.contributor.authorVitry, A.-
dc.contributor.authorWright, J.-
dc.date.issued2005-
dc.identifier.citationMedical Journal of Australia, 2005; 182(4):197-197-
dc.identifier.issn0025-729X-
dc.identifier.issn1326-5377-
dc.identifier.urihttp://hdl.handle.net/2440/48163-
dc.description.statementofresponsibilityPeter R Mansfield, Agnés I Vitry and James M Wright-
dc.language.isoen-
dc.publisherAustralasian Med Publ Co Ltd-
dc.source.urihttp://www.mja.com.au/public/issues/182_04_210205/matters_arising_210205_fm-1.html-
dc.subjectHumans-
dc.subjectCardiovascular Diseases-
dc.subjectProduct Surveillance, Postmarketing-
dc.subjectDrug and Narcotic Control-
dc.subjectCyclooxygenase 2 Inhibitors-
dc.titleWithdraw all COX-2-selective drugs-
dc.typeJournal article-
dc.identifier.doi10.5694/j.1326-5377.2005.tb06654.x-
pubs.publication-statusPublished-
dc.identifier.orcidMansfield, P. [0009-0006-6697-8687]-
Appears in Collections:Aurora harvest 6
General Practice publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.